Grifols in talks to sell Raas stake to China Resources, Bloomberg says

China Resources Holdings is considering buying a minority stake in Shanghai Raas Blood Products from Grifols, Manuel Baigorri and Vinicy Chan of Bloomberg report, citing people familiar with the matter. The companies are in talks about a potential transaction that would help Raas cut its debt load, sources told Bloomberg. Other healthcare companies and investment firms have shown interest in acquiring the stake, the people added. Grifols owns a 26% stake in Shanghai Raas, Bloomberg notes.